Retrospective Evaluation of The Cases with Malignant Pheochromocytoma: A Single Center Experience
Open Access
- 7 March 2021
- journal article
- Published by Turkish Journal of Internal Medicine in Turkish Journal of Internal Medicine
- Vol. 3 (Supplement), 31-33
- https://doi.org/10.46310/tjim.876517
Abstract
IIntroduction The aim of this study was to evaluate the clinicodemographic factors and features of tumors in patients with malignant pheochromocytoma. Methods: We retrospectively evaluated the data of 5 cases admitted to our department between 2013 and 2020 and diagnosed with malignant pheochromocytoma. Results: The patients included three females with mean age of 45 years at presentation. Three cases were diagnosed with pheochromocytoma after hypertensive attack and two cases were diagnosed after detection of adrenal mass. The average diameter of the adrenal mass of the cases was 58 mm. Extesion to periadrenal adipose tissue was detected in two patients, vascular invasion in one patient, and capsule invasion in 1 patient in the surgery-resected specimen. Intraabdominal lymph node metastasis was found in 1 patient and metastatic focus was seen in the liver in 1 patient at the time of the diagnosis. During follow-up, perirenal region metastasis was detected in 1 patient. Bone metastasis was seen in 3 patients, lymph node metastasis in 2 patients and lung metastasis in 1 patient. Transperitoneal surrenalectomy was performed in all cases. Lutetium-177, radiotherapy and surgery were the preferred adjuvant therapies. Three patients died because of progression of the disease or acute complications and the other 2 patients are still under follow-up in our clinic. Conclusion: Malignant pheochromocytoma is rare and definitive criteria for malignancy is not established. Prognosis is poor and there is no curative treatment. Resection of malignant pheochromocytoma with intent to cure, which may improve symptoms and possibly survival is important.Keywords
This publication has 16 references indexed in Scilit:
- Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 YearsJournal of Clinical Endocrinology & Metabolism, 2017
- Clinical Spectrum of PheochromocytomaJournal of the American College of Surgeons, 2009
- Pheochromocytoma and Extra-adrenal Paraganglioma: UpdatesArchives of Pathology & Laboratory Medicine, 2008
- Does iodine‐131 meta‐iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?Clinical Endocrinology, 2004
- Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patientsActa Endocrinologica, 2004
- Recent Advances in Genetics, Diagnosis, Localization, and Treatment of PheochromocytomaAnnals of Internal Medicine, 2001
- Clinical Experience Over 48 Years With PheochromocytomaAnnals of Surgery, 1999
- The diagnosis of malignancy in phaeochromocytomaClinical Endocrinology, 1996
- Malignant Pheochromocytoma with Hepatic Metastasis Diagnosed 20 Years after Resection of the Primary Adrenal Lesion.Internal Medicine, 1993
- A Simplified Diagnostic Approach to Pheochromocytoma A Review of the Literature and Report of One Institutionʼs ExperienceMedicine, 1991